Skip to main content
Top
Published in: Thrombosis Journal 1/2024

Open Access 01-12-2024 | Phlebothrombosis | Research

Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function

Authors: Kun Zhou, Na Li, Jia Qi, Pingping Tu, Yan Yang, Hui Duan

Published in: Thrombosis Journal | Issue 1/2024

Login to get access

Abstract

Background

Deep venous thrombosis (DVT) is the common clinical cardiovascular disease, and easily develops into post-thrombotic syndrome (PTS). The study aimed to examine the clinical value of long non-coding RNA NORAD gene in the development of DVT and PTS. In vitro, the underlying mechanism was explored.

Methods

Serum levels of lncRNA NORAD gene in 85 DVT cases and 85 healthy individuals were tested. The role of lncRNA NORAD gene in human umbilical vein endothelial cells (HUVECs) proliferation, migration and inflammation was examined. The candidate downstream target gene was predicted via bioinformatic analysis. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were done for the function annotation and pathway enrichment.

Results

LncRNA NORAD gene was at high expression in the serum of DVT patients, it can distinguish DVT patients from healthy controls with the area under the curve of 0.919. Elevated expression of lncRNA NORAD gene in PTS patients was detected, DVT cases with high expression of lncRNA NORAD gene were more susceptible to PTS. LncRNA NORAD gene knockdown promoted HUVECs’ proliferation, migration while suppressing cell apoptosis and inflammation. MiR-93-5p served as a target of lncRNA NORAD gene, and its overexpression reversed the role of lncRNA NORAD gene in the biological function of HUVECs. The target genes of miR-93-5p were enriched in HIF-1 signaling, TGF-beta signaling and PI3K-Akt signaling, protein-protein interaction (PPI) network indicated STAT3, MAPK1 to be the key targets.

Conclusions

Upregulation of expression of lncRNA NORAD gene was a potential diagnostic biomarker for DVT and related to the development of PTS. LncRNA NORAD/miR-93-5p axis was involved in the progress of DVT through regulating endothelial cell function.
Appendix
Available only for authorised users
Literature
2.
go back to reference Tang J, Wen Z. Color Doppler diagnosis of Abdominal and Peripheral Vascularity. People’s Medical Publishing House; 2007. Tang J, Wen Z. Color Doppler diagnosis of Abdominal and Peripheral Vascularity. People’s Medical Publishing House; 2007.
3.
go back to reference Hou H, Ge Z, Ying P, Dai J, Shi D, Xu Z, Chen D, Jiang Q. Biomarkers of deep venous Thrombosis. J Thromb Thrombolysis. 2012;34:335–46.CrossRefPubMed Hou H, Ge Z, Ying P, Dai J, Shi D, Xu Z, Chen D, Jiang Q. Biomarkers of deep venous Thrombosis. J Thromb Thrombolysis. 2012;34:335–46.CrossRefPubMed
4.
go back to reference Jin J, Wang C, Ouyang Y, Zhang D. Elevated mir-195-5p expression in deep vein Thrombosis and mechanism of action in the regulation of vascular endothelial cell physiology. Exp Ther Med. 2019;18:4617–24.PubMedPubMedCentral Jin J, Wang C, Ouyang Y, Zhang D. Elevated mir-195-5p expression in deep vein Thrombosis and mechanism of action in the regulation of vascular endothelial cell physiology. Exp Ther Med. 2019;18:4617–24.PubMedPubMedCentral
5.
go back to reference Visona A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P. European Society of Vascular M: post-thrombotic syndrome. Vasa. 2021;50:331–40.CrossRefPubMed Visona A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P. European Society of Vascular M: post-thrombotic syndrome. Vasa. 2021;50:331–40.CrossRefPubMed
6.
go back to reference Kahn SR. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program. 2016;2016:413–8.CrossRef Kahn SR. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program. 2016;2016:413–8.CrossRef
7.
go back to reference Lou Z, Zhu J, Li X, Li X, Du K, Wang B, Zhang F, Zhang X. LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous Thrombosis. Aging. 2021;13:6918–35.CrossRefPubMedPubMedCentral Lou Z, Zhu J, Li X, Li X, Du K, Wang B, Zhang F, Zhang X. LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous Thrombosis. Aging. 2021;13:6918–35.CrossRefPubMedPubMedCentral
8.
go back to reference Wang S, Wang F, Ren J, Yang H. LncRNA NEAT1 promotes vascular endothelial cell dysfunction via miR-218-5p/GAB2 and serves as a diagnostic biomarker for deep vein Thrombosis. Clin Appl Thromb Hemost. 2023;29:10760296231179447.CrossRefPubMedPubMedCentral Wang S, Wang F, Ren J, Yang H. LncRNA NEAT1 promotes vascular endothelial cell dysfunction via miR-218-5p/GAB2 and serves as a diagnostic biomarker for deep vein Thrombosis. Clin Appl Thromb Hemost. 2023;29:10760296231179447.CrossRefPubMedPubMedCentral
9.
go back to reference Cao G, Zhou H, Wang D, Xu L. Knockdown of lncRNA XIST ameliorates IL-1beta-Induced apoptosis of HUVECs and Change of Tissue Factor Level via miR-103a-3p/HMGB1 Axis in deep venous Thrombosis by regulating the ROS/NF-kappaB signaling pathway. Cardiovasc Ther. 2022;2022:6256384.CrossRefPubMedPubMedCentral Cao G, Zhou H, Wang D, Xu L. Knockdown of lncRNA XIST ameliorates IL-1beta-Induced apoptosis of HUVECs and Change of Tissue Factor Level via miR-103a-3p/HMGB1 Axis in deep venous Thrombosis by regulating the ROS/NF-kappaB signaling pathway. Cardiovasc Ther. 2022;2022:6256384.CrossRefPubMedPubMedCentral
10.
go back to reference Guo Y, Yang JH, He Y, Zhou HF, Wang Y, Ding ZS, Jin B, Wan HT. Protocatechuic aldehyde prevents ischemic injury by attenuating brain microvascular endothelial cell pyroptosis via lncRNA. Xist Phytomedicine. 2022;94:153849.CrossRefPubMed Guo Y, Yang JH, He Y, Zhou HF, Wang Y, Ding ZS, Jin B, Wan HT. Protocatechuic aldehyde prevents ischemic injury by attenuating brain microvascular endothelial cell pyroptosis via lncRNA. Xist Phytomedicine. 2022;94:153849.CrossRefPubMed
11.
go back to reference Qian W, Zheng ZQ, Nie JG, Liu LJ, Meng XZ, Sun H, Xiao FM, Kang T. LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR-25-3p/SIRT6 pathway. J Leukoc Biol. 2021;110:651–61.CrossRefPubMed Qian W, Zheng ZQ, Nie JG, Liu LJ, Meng XZ, Sun H, Xiao FM, Kang T. LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR-25-3p/SIRT6 pathway. J Leukoc Biol. 2021;110:651–61.CrossRefPubMed
12.
go back to reference Kai H, Wu Q, Yin R, Tang X, Shi H, Wang T, Zhang M, Pan C. LncRNA NORAD promotes vascular endothelial cell Injury and Atherosclerosis through suppressing VEGF gene transcription via enhancing H3K9 deacetylation by recruiting HDAC6. Front Cell Dev Biol. 2021;9:701628.CrossRefPubMedPubMedCentral Kai H, Wu Q, Yin R, Tang X, Shi H, Wang T, Zhang M, Pan C. LncRNA NORAD promotes vascular endothelial cell Injury and Atherosclerosis through suppressing VEGF gene transcription via enhancing H3K9 deacetylation by recruiting HDAC6. Front Cell Dev Biol. 2021;9:701628.CrossRefPubMedPubMedCentral
13.
go back to reference Fu DN, Wang Y, Yu LJ, Liu MJ, Zhen D. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Kruppel-like factor 5. Exp Cell Res. 2021;401:112519.CrossRefPubMed Fu DN, Wang Y, Yu LJ, Liu MJ, Zhen D. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Kruppel-like factor 5. Exp Cell Res. 2021;401:112519.CrossRefPubMed
14.
go back to reference Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis: definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879–83.CrossRefPubMed Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis: definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879–83.CrossRefPubMed
15.
go back to reference Chu C, Wang B, Zhang Z, Liu W, Sun S, Liang G, Zhang X, An H, Wei R, Zhu X, et al. miR-513c-5p suppression aggravates pyroptosis of endothelial cell in deep venous Thrombosis by promoting Caspase-1. Front Cell Dev Biol. 2022;10:838785.CrossRefPubMedPubMedCentral Chu C, Wang B, Zhang Z, Liu W, Sun S, Liang G, Zhang X, An H, Wei R, Zhu X, et al. miR-513c-5p suppression aggravates pyroptosis of endothelial cell in deep venous Thrombosis by promoting Caspase-1. Front Cell Dev Biol. 2022;10:838785.CrossRefPubMedPubMedCentral
16.
go back to reference Yilmaz MB, Durdag E, Egemen E, Coskun B, Emmez H, Kurt G, Ilgit E. Role of vena cava inferior filter on neurosurgical deep venous Thrombosis. Turk Neurosurg. 2012;22:269–73.PubMed Yilmaz MB, Durdag E, Egemen E, Coskun B, Emmez H, Kurt G, Ilgit E. Role of vena cava inferior filter on neurosurgical deep venous Thrombosis. Turk Neurosurg. 2012;22:269–73.PubMed
17.
go back to reference Zhi L, Feng W, Liang J, Zhong Q, Ren L, Ma J, Yao S, Liqiang Zhi WF. Jingqi Liang contributed equally to this w: the Effect of Common variants in SLC44A2 on the contribution to the risk of deep Cein Thrombosis after orthopedic Surgery. J Atheroscler Thromb. 2021;28:293–303.CrossRefPubMedPubMedCentral Zhi L, Feng W, Liang J, Zhong Q, Ren L, Ma J, Yao S, Liqiang Zhi WF. Jingqi Liang contributed equally to this w: the Effect of Common variants in SLC44A2 on the contribution to the risk of deep Cein Thrombosis after orthopedic Surgery. J Atheroscler Thromb. 2021;28:293–303.CrossRefPubMedPubMedCentral
18.
go back to reference Erol ME, Ozyalcin S, Tekin KA, Diken AI, Yalcinkaya A, Unal EU. Factors affecting recanalization in Femoropopliteal Deep vein Thrombosis. Clin Appl Thromb Hemost. 2023;29:10760296231173409.CrossRefPubMedPubMedCentral Erol ME, Ozyalcin S, Tekin KA, Diken AI, Yalcinkaya A, Unal EU. Factors affecting recanalization in Femoropopliteal Deep vein Thrombosis. Clin Appl Thromb Hemost. 2023;29:10760296231173409.CrossRefPubMedPubMedCentral
19.
go back to reference Hu G, Wang J. Percutaneous endovenous intervention versus anticoagulation in the treatment of lower extremity deep vein Thrombosis: a systematic review and meta-analysis. Ann Transl Med. 2022;10:1018.CrossRefPubMedPubMedCentral Hu G, Wang J. Percutaneous endovenous intervention versus anticoagulation in the treatment of lower extremity deep vein Thrombosis: a systematic review and meta-analysis. Ann Transl Med. 2022;10:1018.CrossRefPubMedPubMedCentral
20.
go back to reference Ariyanti F, Sukrisman L, Antono D, Harimurti K. The risk for post-thrombotic syndrome of subjects with deep vein Thrombosis in an Indonesian referral hospital: a retrospective cohort study. Thromb J. 2023;21:38.CrossRefPubMedPubMedCentral Ariyanti F, Sukrisman L, Antono D, Harimurti K. The risk for post-thrombotic syndrome of subjects with deep vein Thrombosis in an Indonesian referral hospital: a retrospective cohort study. Thromb J. 2023;21:38.CrossRefPubMedPubMedCentral
21.
go back to reference Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic Disease. J Thromb Haemost. 2005;3:2671–6.CrossRefPubMed Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic Disease. J Thromb Haemost. 2005;3:2671–6.CrossRefPubMed
22.
go back to reference McLendon K, Goyal A, Attia M. Deep venous Thrombosis risk factors. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies. Disclosure: Maximos Attia declares no relevant financial relationships with ineligible companies.; 2023. McLendon K, Goyal A, Attia M. Deep venous Thrombosis risk factors. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies. Disclosure: Maximos Attia declares no relevant financial relationships with ineligible companies.; 2023.
23.
go back to reference Zhao X, Wei X, Wang X, Qi G. Long non–coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR–590–3p under hypoxic conditions. Mol Med Rep. 2020;21:2560–70.PubMedPubMedCentral Zhao X, Wei X, Wang X, Qi G. Long non–coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR–590–3p under hypoxic conditions. Mol Med Rep. 2020;21:2560–70.PubMedPubMedCentral
24.
go back to reference Ma J, Li X, Wang Y, Yang Z, Luo J. Rivaroxaban attenuates Thrombosis by targeting the NF-kappaB signaling pathway in a rat model of deep venous thrombus. Int J Mol Med. 2017;40:1869–80.PubMedPubMedCentral Ma J, Li X, Wang Y, Yang Z, Luo J. Rivaroxaban attenuates Thrombosis by targeting the NF-kappaB signaling pathway in a rat model of deep venous thrombus. Int J Mol Med. 2017;40:1869–80.PubMedPubMedCentral
25.
go back to reference Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA interactions. Methods Mol Biol. 2016;1402:271–86.CrossRefPubMed Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA interactions. Methods Mol Biol. 2016;1402:271–86.CrossRefPubMed
26.
go back to reference Pan Z, Zhang Y, Li C, Yin Y, Liu R, Zheng G, Fan W, Zhang Q, Song Z, Guo Z, et al. MiR-296-5p ameliorates deep venous Thrombosis by inactivating S100A4. Exp Biol Med (Maywood). 2021;246:2259–68.CrossRefPubMed Pan Z, Zhang Y, Li C, Yin Y, Liu R, Zheng G, Fan W, Zhang Q, Song Z, Guo Z, et al. MiR-296-5p ameliorates deep venous Thrombosis by inactivating S100A4. Exp Biol Med (Maywood). 2021;246:2259–68.CrossRefPubMed
27.
go back to reference Han J, Hao W, Ma Y, Hou Y. MiR-128-3p promotes the progression of deep venous Thrombosis through binding SIRT1. Phlebology 2023:2683555231190268. Han J, Hao W, Ma Y, Hou Y. MiR-128-3p promotes the progression of deep venous Thrombosis through binding SIRT1. Phlebology 2023:2683555231190268.
28.
go back to reference Ma SX, Bai ZF, Wang W, Wu HY. Effects of microrna-93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF-KappaB pathway. J Cell Biochem. 2019;120:2847–58.CrossRefPubMed Ma SX, Bai ZF, Wang W, Wu HY. Effects of microrna-93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF-KappaB pathway. J Cell Biochem. 2019;120:2847–58.CrossRefPubMed
29.
go back to reference He Z, Wang H, Yue L. Endothelial progenitor cells-secreted extracellular vesicles containing microRNA-93-5p confer protection against sepsis-induced acute kidney injury via the KDM6B/H3K27me3/TNF-alpha axis. Exp Cell Res. 2020;395:112173.CrossRefPubMed He Z, Wang H, Yue L. Endothelial progenitor cells-secreted extracellular vesicles containing microRNA-93-5p confer protection against sepsis-induced acute kidney injury via the KDM6B/H3K27me3/TNF-alpha axis. Exp Cell Res. 2020;395:112173.CrossRefPubMed
30.
go back to reference Kellermair J, Redwan B, Alias S, Jabkowski J, Panzenboeck A, Kellermair L, Winter MP, Weltermann A, Lang IM. Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution. Blood. 2013;122:3376–84.CrossRefPubMed Kellermair J, Redwan B, Alias S, Jabkowski J, Panzenboeck A, Kellermair L, Winter MP, Weltermann A, Lang IM. Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution. Blood. 2013;122:3376–84.CrossRefPubMed
31.
go back to reference Altmann J, Sharma S, Lang IM. Advances in our understanding of mechanisms of venous thrombus resolution. Expert Rev Hematol. 2016;9:69–78.CrossRefPubMed Altmann J, Sharma S, Lang IM. Advances in our understanding of mechanisms of venous thrombus resolution. Expert Rev Hematol. 2016;9:69–78.CrossRefPubMed
32.
go back to reference Wang X, Sundquist K, Svensson PJ, Rastkhani H, Palmer K, Memon AA, Sundquist J, Zoller B. Association of recurrent venous thromboembolism and circulating microRNAs. Clin Epigenetics. 2019;11:28.CrossRefPubMedPubMedCentral Wang X, Sundquist K, Svensson PJ, Rastkhani H, Palmer K, Memon AA, Sundquist J, Zoller B. Association of recurrent venous thromboembolism and circulating microRNAs. Clin Epigenetics. 2019;11:28.CrossRefPubMedPubMedCentral
33.
go back to reference Sadia K, Ashraf MZ, Mishra A. Therapeutic role of Sirtuins Targeting unfolded protein response, Coagulation, and inflammation in Hypoxia-Induced Thrombosis. Front Physiol. 2021;12:733453.CrossRefPubMedPubMedCentral Sadia K, Ashraf MZ, Mishra A. Therapeutic role of Sirtuins Targeting unfolded protein response, Coagulation, and inflammation in Hypoxia-Induced Thrombosis. Front Physiol. 2021;12:733453.CrossRefPubMedPubMedCentral
34.
go back to reference Mo JW, Zhang DF, Ji GL, Liu XZ, Fan B. TGF-beta1 and Serpine 1 expression changes in traumatic deep vein Thrombosis. Genet Mol Res. 2015;14:13835–42.CrossRefPubMed Mo JW, Zhang DF, Ji GL, Liu XZ, Fan B. TGF-beta1 and Serpine 1 expression changes in traumatic deep vein Thrombosis. Genet Mol Res. 2015;14:13835–42.CrossRefPubMed
35.
go back to reference Wang P, Pan Y, Yang C, Zhang L, Zhao Z, Ye K, Li L, Xia S, Lu X, Shi H, et al. TNFalpha activation and TGFbeta blockage act synergistically for smooth muscle cell calcification in patients with venous Thrombosis via TGFbeta/ERK pathway. J Cell Mol Med. 2022;26:4479–91.CrossRefPubMedPubMedCentral Wang P, Pan Y, Yang C, Zhang L, Zhao Z, Ye K, Li L, Xia S, Lu X, Shi H, et al. TNFalpha activation and TGFbeta blockage act synergistically for smooth muscle cell calcification in patients with venous Thrombosis via TGFbeta/ERK pathway. J Cell Mol Med. 2022;26:4479–91.CrossRefPubMedPubMedCentral
36.
go back to reference Kowalewski R, Malkowski A, Gacko M, Sobolewski K. Influence of thrombophlebitis on TGF-beta1 and its signaling pathway in the vein wall. Folia Histochem Cytobiol. 2010;48:542–8.PubMed Kowalewski R, Malkowski A, Gacko M, Sobolewski K. Influence of thrombophlebitis on TGF-beta1 and its signaling pathway in the vein wall. Folia Histochem Cytobiol. 2010;48:542–8.PubMed
37.
go back to reference Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, Zeng Q, Xu M, Tang QZ. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-kappaB pathways. Acta Pharmacol Sin. 2022;43:1989–2002.CrossRefPubMed Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, Zeng Q, Xu M, Tang QZ. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-kappaB pathways. Acta Pharmacol Sin. 2022;43:1989–2002.CrossRefPubMed
38.
go back to reference Meng Y, Yin Q, Ma Q, Qin H, Zhang J, Zhang B, Pang H, Tian H. FXII regulates the formation of deep vein Thrombosis via the PI3K/AKT signaling pathway in mice. Int J Mol Med 2021, 47. Meng Y, Yin Q, Ma Q, Qin H, Zhang J, Zhang B, Pang H, Tian H. FXII regulates the formation of deep vein Thrombosis via the PI3K/AKT signaling pathway in mice. Int J Mol Med 2021, 47.
39.
go back to reference Wei X, Zhang B, Wei F, Ding M, Luo Z, Han X, Tan X. Gegen Qinlian pills alleviate carrageenan-induced Thrombosis in mice model by regulating the HMGB1/NF-kappaB/NLRP3 signaling. Phytomedicine. 2022;100:154083.CrossRefPubMedPubMedCentral Wei X, Zhang B, Wei F, Ding M, Luo Z, Han X, Tan X. Gegen Qinlian pills alleviate carrageenan-induced Thrombosis in mice model by regulating the HMGB1/NF-kappaB/NLRP3 signaling. Phytomedicine. 2022;100:154083.CrossRefPubMedPubMedCentral
Metadata
Title
Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function
Authors
Kun Zhou
Na Li
Jia Qi
Pingping Tu
Yan Yang
Hui Duan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2024
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-023-00575-3

Other articles of this Issue 1/2024

Thrombosis Journal 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.